Martingale Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.8K | Sell |
20,083
-2,826
| -12% | -$13.3K | ﹤0.01% | 776 |
|
|
2025
Q1 | $105K | Sell |
22,909
-41,900
| -65% | -$192K | ﹤0.01% | 758 |
|
|
2024
Q4 | $310K | Sell |
64,809
-5,200
| -7% | -$24.9K | 0.01% | 685 |
|
|
2024
Q3 | $328K | Sell |
70,009
-5,506
| -7% | -$25.8K | 0.01% | 701 |
|
|
2024
Q2 | $427K | Hold |
75,515
| – | – | 0.01% | 632 |
|
|
2024
Q1 | $310K | Buy |
75,515
+3,011
| +4% | +$12.4K | 0.01% | 706 |
|
|
2023
Q4 | $306K | Sell |
72,504
-7,718
| -10% | -$32.6K | 0.01% | 696 |
|
|
2023
Q3 | $347K | Buy |
80,222
+13,250
| +20% | +$57.2K | 0.01% | 663 |
|
|
2023
Q2 | $441K | Buy |
66,972
+18,303
| +38% | +$121K | 0.01% | 636 |
|
|
2023
Q1 | $330K | Sell |
48,669
-30,496
| -39% | -$207K | 0.01% | 695 |
|
|
2022
Q4 | $585K | Buy |
79,165
+2,520
| +3% | +$18.6K | 0.01% | 591 |
|
|
2022
Q3 | $758K | Buy |
76,645
+52,127
| +213% | +$516K | 0.02% | 517 |
|
|
2022
Q2 | $268K | Sell |
24,518
-5,400
| -18% | -$59K | ﹤0.01% | 759 |
|
|
2022
Q1 | $339K | Sell |
29,918
-46,518
| -61% | -$527K | 0.01% | 708 |
|
|
2021
Q4 | $1.2M | Sell |
76,436
-3,500
| -4% | -$54.9K | 0.02% | 446 |
|
|
2021
Q3 | $1.37M | Buy |
79,936
+13,700
| +21% | +$235K | 0.02% | 427 |
|
|
2021
Q2 | $1.43M | Sell |
66,236
-1,900
| -3% | -$40.9K | 0.02% | 316 |
|
|
2021
Q1 | $1.03M | Buy |
68,136
+5,909
| +9% | +$88.9K | 0.01% | 414 |
|
|
2020
Q4 | $818K | Buy |
62,227
+7,203
| +13% | +$94.7K | 0.01% | 492 |
|
|
2020
Q3 | $532K | Sell |
55,024
-44,500
| -45% | -$430K | 0.01% | 798 |
|
|
2020
Q2 | $1.14M | Buy |
+99,524
| New | +$1.14M | 0.01% | 699 |
|